Showing results (101-110 of 715) with videos related to

Sort By:
Pageof 72
Medicina Clinica|March 24, 2012
[Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection]Sergio Serrano-Villar, Vicente Estrada, Dulcenombre Gómez-Garre, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 2012
Association of HIV-Infection and antiretroviral therapy with levels of endothelial progenitor cells and subclinical atherosclerosisDulcenombre Gómez-Garre, Vicente Estrada, Adriana Ortega-Hernández, et al.
AIDS (London, England)|December 7, 2016
HIV, HPV, and microbiota: partners in crime?Sergio Serrano-Villar, Emilia Vásquez-Domínguez, José Antonio Pérez-Molina, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2012
The activity of the integrase inhibitor dolutegravir against HIV-1 variants isolated from raltegravir-treated adultsMark R Underwood, Brian A Johns, Akihiko Sato, et al.
AIDS (London, England)|April 26, 2011
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected personsAndy I Choi, Eric Vittinghoff, Steven G Deeks, et al.
The Journal of Infectious Diseases|September 27, 2003
Assessing resistance costs of antiretroviral therapies via measures of future drug optionsHongyu Jiang, Steven G Deeks, Daniel R Kuritzkes, et al.
Circulation|January 27, 2010
Association between kidney function and albuminuria with cardiovascular events in HIV-infected personsAndy I Choi, Yongmei Li, Steven G Deeks, et al.
Pageof 72